2014-01-27 – Page 3 – China Stock Advice

LITB [LightInTheBox] 6-K: LightInTheBox Holding Co., Ltd. Announces Management Change Beijing,

[LightInTheBox Holding Co., Ltd. Announces Management Change Beijing, China, January 27 , 2014 - LightInTheBox Holding Co., Ltd. (NYSE: LITB) (LightInTheBox or the Company), a global online retail company that delivers products directly to consumers around the world, today announced that its Chief Financial Officer Mr. Richard Xue has decided to leave the company due to personal reasons effective on] [TABLE OF CONTENTS 2 LIGHTINTHEBOX HOLDING CO., LTD.]

By info| 2016-03-28T00:34:45+00:00 January 27th, 2014|Categories: Chinese Stocks, LITB, Webplus ver|Tags: 0001523836, 2014-01-27, 5961, 6-K, LITB, RETAIL-CATALOG and MAIL-ORDER HOUSES|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Holds 2013 Annual General Meeting of Shareholders BEIJING, Aug. 21, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2013 Annual General Meeting of Shareholders on Wednesday, August 21, 2013 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted] [Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013 BEIJING, Oct. 31, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President and CEO of Sinovac, is invited to participate in UBS Asia Healthcare CEO Summit held in Hong Kong on November 1,] [Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results EIJING, Nov. 4, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2013, after market closes on Tuesday, November 12, 2013 EST. The Company] [Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive(R) under Expanded Immunization Program BEIJING, Nov. 7, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has been selected by the Jiangsu Centers for Disease Control and Prevention (Jiangsu CDC) to supply the Company's inactivated hepatitis A vaccine, Healive, under the] [Sinovac Reports Unaudited Third Quarter 2013 Financial Results - Conference call scheduled for Wednesday, November 13, 2013 at 8:00 AM EST - BEIJING, Nov. 12, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for for the three and nine months ended September 30, 2013. 2013] []

By info| 2016-03-16T09:20:51+00:00 January 27th, 2014|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2014-01-27, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)

[GYMCL Unveils 8 New Engines for 2014 Singapore, Singapore, January 27, 2014 China Yuchai International Limited (NYSE: CYD) To better meet the needs of the truck and bus markets in China, several new engine models were introduced, all meeting the National IV emission standards: paired with EGR, DOC and POC technologies. Its power range covers 103-118 KW and] [FORM 6-K January 27, 2014 China Yuchai International Limited 16 Raffles Quay #26-00 x x n/a China Yuchai International Limited Weng Ming Hoh President/Director Description 99 Press release dated January 27, 2014 – GYMCL Unveils 8 New Engines for 2014 6-K 1 htm_8278.htm LIVE FILING]

By info| 2016-03-28T13:40:21+00:00 January 27th, 2014|Categories: Chinese Stocks, CYD, SEC Original|Tags: 0000932695, 2014-01-27, 3510, 6-K, CYD, ENGINES and TURBINES|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Holds 2013 Annual General Meeting of Shareholders

[Sinovac Holds 2013 Annual General Meeting of Shareholders BEIJING, Aug. 21, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2013 Annual General Meeting of Shareholders on Wednesday, August 21, 2013 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted] [Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013 BEIJING, Oct. 31, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President and CEO of Sinovac, is invited to participate in UBS Asia Healthcare CEO Summit held in Hong Kong on November 1,] [Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results EIJING, Nov. 4, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2013, after market closes on Tuesday, November 12, 2013 EST. The Company] [Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive(R) under Expanded Immunization Program BEIJING, Nov. 7, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has been selected by the Jiangsu Centers for Disease Control and Prevention (Jiangsu CDC) to supply the Company's inactivated hepatitis A vaccine, Healive, under the] [Sinovac Reports Unaudited Third Quarter 2013 Financial Results - Conference call scheduled for Wednesday, November 13, 2013 at 8:00 AM EST - BEIJING, Nov. 12, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for for the three and nine months ended September 30, 2013. 2013] []

By info| 2016-03-16T09:23:32+00:00 January 27th, 2014|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2014-01-27, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: GYMCL Unveils 8 New Engines for 2014 Singapore,

[GYMCL Unveils 8 New Engines for 2014 Singapore, Singapore, January 27, 2014 China Yuchai International Limited (NYSE: CYD) To better meet the needs of the truck and bus markets in China, several new engine models were introduced, all meeting the National IV emission standards: paired with EGR, DOC and POC technologies. Its power range covers 103-118 KW and] [FORM 6-K January 27, 2014 China Yuchai International Limited 16 Raffles Quay #26-00 x x n/a China Yuchai International Limited Weng Ming Hoh President/Director Description 99 Press release dated January 27, 2014 – GYMCL Unveils 8 New Engines for 2014 6-K 1 htm_8278.htm LIVE FILING]